Suzanne de Bruijn

200 Chapter 4 Table S3. qPCR primers Target Primer Oligonucleotides (5’-3’) SMG8 exons 3-4, mRNA Forward ACTAATGCCTCAGGTTCAGC Reverse ATCTCAAAACCCAAAGGCCA GDPD1 exons 3-5, mRNA Forward ATACTGTGAGCTCCCACCTTAC Reverse GGAGTGTTAGGAAAGGCCTCAA YPEL2 exons 2-4, mRNA Forward TCACTGCAGAGCTCACTTGG Reverse CCACAGCCCACATTAACTACTGA TRIM37 exons 11-12, mRNA Forward GCGTCAGAGAGCAGATCC Reverse GCACAACTCCATTTCCATCTG NRL exons 3-3, mRNA Forward GGCTCCACACCTTACAGCTC Reverse AGCCAGTACAGCTCCTCCAG CRX exons 2-3, mRNA Forward GCCCCACTATTCTGTCAACG Reverse CTTCAGAGCCACCTCCTCAC ACTB exons 3-4, mRNA Forward CCAACCGCGAGAAGATGA Reverse CCAGAGGCGTACAGGGATAG GUSB exons 2-3, mRNA Forward AGAGTGGTGCTGAGGATTGG Reverse CCCTCATGCTCTAGCGTGTC Retinal enhancer, eRNA Forward ACCTGCCTGTACGAATCCAA Reverse CTGGGAGGAGGCAAATTGTA SMG8 exon 4 Forward CCTGGAAAGAGAAGTGCGGT Triplication qPCR 1 Reverse AGGCCCAGAGCACATGAATC GDPD1 intron 1 Forward TGTGAATTGAGGGCTCTTCCG Triplication qPCR 2 Reverse ACCGTGTCTTTCCCGTTTCA Downstream of YPEL2 Forward AAGGTCAGCGTTCTCTCAGAAG Triplication qPCR 3 Reverse TGTTGAGTTCTGTCTGCCTCG LINC01476 intron 2 Forward CCTGCAACCTAACCCTAAGC Triplication qPCR 4 Reverse GCATGCCAGATCGCTGTTG